Artiva Biotherapeutics, Inc. · NASDAQ:ARTV

Aslan Fred received 45,000 Artiva Biotherapeutics, Inc. shares as an award (Form 4)

Traded Sep 10, 2026 · Filed Sep 14, 2026

On Sep 10, 2026, Aslan Fred (Director, Chief Executive Officer) received 45,000 Artiva Biotherapeutics, Inc. shares as an award, leaving 1,494,765 shares. Filed Sep 14, 2026 (Form 4).

Awarded
45,000 shares
Holding after
1,494,765 shares
Trading plan
No
Role
Director, Chief Executive Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Sep 10, 2026Common StockAward45,0001,494,765Direct

Source

View original at SEC

Related